STUDY ON NT-PROBNP PLASMA LEVELS IN PATIENTS AFTER PERMANENT PACEMAKER IMPLANTATION

Giang Trần Song, Quang Hoàng Minh, Thường Bùi Văn

Main Article Content

Abstract

Objective: To evaluate the changes in plasma NT-proBNP levels before and after permanent pacemaker implantation, as well as the relationship between post-implantation plasma NT-proBNP levels and clinical symptoms, paraclinical tests, and pacemaker parameters in patients with third-degree atrioventricular block (AVB) who received a permanent pacemaker. Subjects and Methods: This is a prospective, cross-sectional, intervention-controlled descriptive study involving 60 patients with third-degree AVB who underwent permanent pacemaker implantation at Vietnam National Heart Institute, Bach Mai Hospital, Dong Do Hospital, and Vietnam-Sweden Hospital in Uong Bi from August 1, 2022 to August 31, 2023. Patients meeting the inclusion criteria were recruited using convenience sampling and divided into two groups: Group 1 consisted of patients who switched to a single-chamber pacing mode post-implantation, while Group 2 included those who maintained a dual-chamber pacing mode. Results: In patients with third-degree AVB who received permanent pacemakers, plasma NT-proBNP levels after implantation were higher than before implantation in both groups. In Group 1, the values were 354.57±249.49 pg/ml before implantation and 495.90±290.28 pg/ml after implantation, with a statistically significant difference (p<0.001). In Group 2, the levels were 568.44±276.53 pg/ml before and 658.96±376.40 pg/ml after implantation, also showing a statistically significant difference (p=0.027). A strong negative correlation was found between plasma NT-proBNP levels and ejection fraction (EF) after permanent pacemaker implantation (r = -0.464, p<0.05) in the dual-chamber pacing group. Conclusion: In patients with third-degree AVB who received permanent pacemakers, plasma NT-proBNP levels were significantly higher post-implantation compared to pre-implantation levels in both the single-chamber and dual-chamber pacing groups. A strong negative correlation existed between plasma NT-proBNP levels and EF between plasma NT-proBNP levels and EF in the dual-chamber pacing group and a moderate positive correlation with right ventricular electrode impedance in the dual-chamber pacing group; however, no such correlation was found in the single-chamber pacing group.

Article Details

References

1. Chen RH, Chen KP, Hua W, et al. The gender difference of utilization of cardiac implantable electronic device in China: data from Arrhythmia Interventional Therapy Data Registry. J Geriatr Cardiol JGC. 2018;15(4):310-314.
2. Lee YS. Bradyarrhythmia Can Increase the Plasma Level of N-Terminal Pro-Brain Natriuretic Peptide. Int J Arrhythmia. October 11, 2016:17(3):112-7.
3. Sriratanasathavorn C, Pumprueg S, Boonyapisit W, Kaosa-ad B, Kangkagate C. The relationship between plasma NT-proBNP level and pacing mode in the patient with implanted permanent pacemaker. J Med Assoc Thail Chotmaihet Thangphaet. 2013;96 Suppl 2:S158-163.
4. Psychari SN, Apostolou TS, Iliodromitis EK, Charalampopoulos A, Kremastinos DT. DDDR pacing results in left ventricular asynchrony with preservation of ejection fraction and NT-proBNP: a prospective study in sick sinus syndrome and normal ventricular function. Int J Cardiol. 2010;144(2):310-312.
5. Naegeli B, Kurz DJ, Koller D, et al. Single-chamber ventricular pacing increases markers of left ventricular dysfunction compared with dual-chamber pacing. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2007;9(3):194-199.
6. Giá trị nồng độ NT-PROBNP huyết tương trong dự báo suy tim ở bệnh nhân đái tháo đường type 2 – Hội Nội Tiết – Đái Tháo Đường Miền Trung Việt Nam. Published online November 13, 2024.
7. Phạm Như Hùng, Trương Quang Việt. Relationship of NT-ProBNP and pacemaker parameters in patients with sick sinus syndrome? 2021:35, 243-247.